Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update

    Thipprapai Mahasaksiri, Chaninan Kositkuljorn, Tanaporn Anuntrangsee, Poonkiat Suchonwanit
    TLDR Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.
    The review discussed the application of topical immunotherapy, particularly diphenylcyclopropenone (DPCP), in treating alopecia areata, highlighting its effectiveness in inducing hair regrowth by modulating immune responses. Studies, including a large retrospective study with 757 patients, showed positive outcomes with DPCP, though success varied among patients. Side effects such as contact dermatitis, pigmentation abnormalities, urticaria, erythema multiforme major, and scalp angioedema were common. The review emphasized the need for further research to optimize treatment protocols, minimize adverse effects, and understand long-term outcomes. Home-based DPCP treatment was found to be as effective and safe as clinic-based treatment, improving patient compliance.
    Discuss this study in the Community →

    Cited in this study

    35 / 35 results

    Related

    1 / 1 results